REFERENCES
- Geddes D M. Inhaled corticosteroids: benefits and risks. Thorax 1992; 47: 404–407, [PUBMED], [INFOTRIEVE], [CSA]
- National Heart, Lung, and Blood Institute. Guidelines for the Diagnosis and Management of Asthma. National Asthma Education Program, Highlights of the Expert Panel Report 2, National Institutes of Health, Bethesda, MD May, 1997, NIH publication 97-4015A
- Mawhinney H, Spector S L, Kinsman R A, Siegel S C, Rachelefsky G S, Katz R M, Rohr A S. Compliance in clinical trials of nonbronchodilator, anti-asthma medications. Ann Allergy 1991; 66: 294–299, [PUBMED], [INFOTRIEVE], [CSA]
- Apter A J, Reisine S T, Affleck G, Barrows E, Zuwallack R L. Adherence with twice-daily dosing of inhaled steroids. AM J Respir Crit Care Med 1998; 157: 1810–1817, [PUBMED], [INFOTRIEVE], [CSA]
- Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: Is there a solution to the problem?. Ann Allergy Asthma Immunol 1997; 79: 177–185, [PUBMED], [INFOTRIEVE], [CSA]
- Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98(6 pt 1)1051–1057, [PUBMED], [INFOTRIEVE], [CSA]
- Tashkin D P. Multiple dose regimens. Impact on compliance. Chest 1995; 107: 176S–182S, [PUBMED], [INFOTRIEVE], [CSA]
- Harding S M. The human pharmacology of fluticasone propionate. Respir Med 1990; 84(Suppl A)25–29, [PUBMED], [INFOTRIEVE], [CSA]
- Derendorf H, Hochhaus G, Meibohm B, Mollmann H, Barth J. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids. J Allergy Clin Immunol 1998; 101: S440–S446, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hogger P, Bonsmann U, Rohdewald P. Distribution and intrinsic activity of inhaled corticosteroids in vitro. Eur J Pharm Sci 1994; 59: 597–602, [CSA]
- Lipworth B J. Systemic bioavailability of fluticasone proprionate. Br J Clin Pharmacol 2001; 52: 457–460, [PUBMED], [INFOTRIEVE], [CSA]
- Esmailpour N, Hogger P, Rabe K F, Heitmann U, Nakashima M, Rohdewald P. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J 1997; 10: 1496–1499, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wolfe J, Rooklin A, Grady J, Monk Z M, Stevens A, Prillaman B, Duke S, Harding S. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by discus device in patients with asthma treated with or without inhaled corticosteroids. J Allergy Clin Immunol 2000; 105: 1153–1161, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ayres J, Bateman E D, Lundback B, Harris T A. High dose fluticasone propionate, 1mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group. Eur Respir J 1995; 8: 579–586, [PUBMED], [INFOTRIEVE], [CSA]
- Berger W E, Ford L B, Mahr T, Nathan R A, Crim C, Edwards L, Wightman D S, Lincourt W R, Rickard K. Efficacy and safety of fluticasone propionate 250 micrograms administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids. Ann Allergy Asthma Immunol 2002; 89: 393–399, [PUBMED], [INFOTRIEVE], [CSA]
- Boulet L P, Cowie R L, Negro R D, Brett W, Gold M, Marques A, Thorburn W S, Stepner N M, Robson R. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma. Can Respir J 2000; 7: 239–247, [PUBMED], [INFOTRIEVE], [CSA]
- Nathan R A, Li J TC, Finn A, Jones R, Payne E, Wolford J P, Harding S M. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma. Chest 2000; 118: 296–302, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- ZuWallack R, Adelglass J, Clifford D P, Duke S P, Wire P D, Faris M, Harding S M. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma. Chest 2000; 118: 303–312, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hodges I, Netherway T. Once daily inhaled fluticasone propionate is as effective as twice daily in children with stable mild to moderate asthma (abstract). Thorax 1998; 53(suppl 4), [CSA]
- LaForce C F, Pearlmaen D S, Ruff M E, Silvers W S, Silvers W S, Weinstein S W, Clements D S, Brown A, Duke S, Harding S M, House K W. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma. Ann Allergy Asthma Immunol 2000; 85: 407–415, [PUBMED], [INFOTRIEVE], [CSA]
- Purucker M E, Rosebraugh C J, Zhou F, Meyer R J. Inhaled fluticasone propionate by diskus in the treatment of asthma: A comparison of the efficacy of the same nominal dose given either once or twice a day. Chest 2003; 124: 1584–1593, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Warner J O. Asthma: A follow up statement from an international paediatric asthma consensus group. Arch Dis Child 1992; 67: 240–248, [CSA]
- Anonymous. Recommendations for standardised procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children – 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999; 160: 2104–2117, [CSA]
- Ip M S, Karlberg E M, Karlberg J P, Luk K D, Leong J C. Lung function reference values in Chinese children and adolescents in Hong Kong. AM J Respir Crit Care Med 2000; 162: 424–429, [PUBMED], [INFOTRIEVE], [CSA]
- Smith C M, Anderson S D. Inhalational challenge using hypertonic saline in asthmatic subjects: A comparison with responses to hyperpnoea, metacholine and water. Eur Respir J 1990; 3: 144–151, [PUBMED], [INFOTRIEVE], [CSA]
- Fahy J V, Boushey H A, Lazarus S C, Mauger E A, Cherniack R M, Chinchilli V M. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. AM J Respir Crit Care Med 2001; 163: 1470–1475, [PUBMED], [INFOTRIEVE], [CSA]
- Crimi E, Spanevello A, Neri M, Ind P W, Rossi G A, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. AM J Respir Crit Care Med 1998; 157: 4–9, [PUBMED], [INFOTRIEVE], [CSA]
- Gibson P G, Henry R L, Thomas P. Noninvasive assessment of airway inflammation in children: Induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J 2000; 16: 1008–1015, [PUBMED], [INFOTRIEVE], [CSA]
- Moller C, Stromberg L, Oldaeus G, Arwestrom E, Kjellman M. Efficacy of once daily administration of budesonide by turbuhaler in children with stable asthma. Pediatr Pulmonol 1999; 28: 337–343, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Campbell L M, Bodalia B, Gogbashian C A, Gunn S D, Humphreys P J, Powell J P. Once-daily budesonide: 400 micrograms once daily is effective as 200 micrograms twice daily in controlling childhood asthma. PETITE Research Group. Int J Clin Pract 1998; 52: 213–219, [PUBMED], [INFOTRIEVE], [CSA]
- Jones A H, Langdon C G, Lee P S, Lingham S A, Nankani J P, Follows R M, Tollemar U, Richardson P D. Pulmicort turbuhaler once daily as initial prophylactic therapy for asthma. Respir Med 1994; 88: 293–299, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]